Endocr Relat Cancer: Most-Cited Full-Text Articles
http://erc.endocrinology-journals.org/
Most-cited rankings are recalculated at the beginning of the month and are based on citations to articles on this journal site from articles in other HighWire-hosted journals.2009-11-09<![CDATA[Fibroblast growth factors, their receptors and signaling]]>
http://erc.endocrinology-journals.org/cgi/content/short/7/3/165?rss=1&ssource=mfc
Sep 1, 2000; 7:165-197 ]]>CJ Powers, SW McLeskey, A Wellstein2000-09-0110.1677/erc.0.0070165Society for Endocrinology<![CDATA[The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification]]>
http://erc.endocrinology-journals.org/cgi/content/short/8/1/11?rss=1&ssource=mfc
Mar 1, 2001; 8:11-31 ]]>N Prenzel, OM Fischer, S Streit, S Hart, A Ullrich2001-03-0110.1677/erc.0.0080011Society for Endocrinology<![CDATA[mTOR, a novel target in breast cancer: the effect of CCI-779, an mTOR inhibitor, in preclinical models of breast cancer]]>
http://erc.endocrinology-journals.org/cgi/content/short/8/3/249?rss=1&ssource=mfc
Sep 1, 2001; 8:249-258 ]]>K Yu, L Toral-Barza, C Discafani, WG Zhang, J Skotnicki, P Frost, JJ Gibbons2001-09-0110.1677/erc.0.0080249Society for Endocrinology<![CDATA[Discovery of a novel Raf kinase inhibitor]]>
http://erc.endocrinology-journals.org/cgi/content/short/8/3/219?rss=1&ssource=mfc
Sep 1, 2001; 8:219-225 ]]>JF Lyons, S Wilhelm, B Hibner, G Bollag2001-09-0110.1677/erc.0.0080219Society for Endocrinology<![CDATA[The IGF system and breast cancer]]>
http://erc.endocrinology-journals.org/cgi/content/short/8/3/197?rss=1&ssource=mfc
Sep 1, 2001; 8:197-209 ]]>D Sachdev, D Yee2001-09-0110.1677/erc.0.0080197Society for Endocrinology<![CDATA[Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells]]>
http://erc.endocrinology-journals.org/cgi/content/short/10/2/179?rss=1&ssource=mfc
Jun 1, 2003; 10:179-186 ]]>SF Doisneau-Sixou, CM Sergio, JS Carroll, R Hui, EA Musgrove, RL Sutherland2003-06-0110.1677/erc.0.0100179Society for Endocrinology<![CDATA[Cyclooxygenase-2: a target for the prevention and treatment of breast cancer]]>
http://erc.endocrinology-journals.org/cgi/content/short/8/2/97?rss=1&ssource=mfc
Jun 1, 2001; 8:97-114 ]]>LR Howe, K Subbaramaiah, AM Brown, AJ Dannenberg2001-06-0110.1677/erc.0.0080097Society for Endocrinology<![CDATA[Involvement of steroid hormone and growth factor cross-talk in endocrine response in breast cancer]]>
http://erc.endocrinology-journals.org/cgi/content/short/6/3/373?rss=1&ssource=mfc
Sep 1, 1999; 6:373-387 ]]>RI Nicholson, RA McClelland, JF Robertson, JM Gee1999-09-0110.1677/erc.0.0060373Society for Endocrinology<![CDATA[Insulin-like growth factor-I receptor signalling and acquired resistance to gefitinib (ZD1839; Iressa) in human breast and prostate cancer cells]]>
http://erc.endocrinology-journals.org/cgi/content/short/11/4/793?rss=1&ssource=mfc
Dec 1, 2004; 11:793-814 Original Research]]>H E Jones, L Goddard, J M W Gee, S Hiscox, M Rubini, D Barrow, J M Knowlden, S Williams, A E Wakeling, R I Nicholson2004-12-0110.1677/erc.1.00799Society for Endocrinology<![CDATA[Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition]]>
http://erc.endocrinology-journals.org/cgi/content/short/12/4/1071?rss=1&ssource=mfc
Dec 1, 2005; 12:1071-1082 Original Research]]>R Kaaks, S Rinaldi, T J Key, F Berrino, P H M Peeters, C Biessy, L Dossus, A Lukanova, S Bingham, K-T Khaw, N E Allen, H B Bueno-de-Mesquita, C H van Gils, D Grobbee, H Boeing, P H Lahmann, G Nagel, J Chang-Claude, F Clavel-Chapelon, A Fournier, A Thiebaut, C A Gonzalez, J R Quiros, M-J Tormo, E Ardanaz, P Amiano, V Krogh, D Palli, S Panico, R Tumino, P Vineis, A Trichopoulou, V Kalapothaki, D Trichopoulos, P Ferrari, T Norat, R Saracci, E Riboli2005-12-0110.1677/erc.1.01038Society for Endocrinology<![CDATA[Modulation of epidermal growth factor receptor in endocrine-resistant, oestrogen receptor-positive breast cancer]]>
http://erc.endocrinology-journals.org/cgi/content/short/8/3/175?rss=1&ssource=mfc
Sep 1, 2001; 8:175-182 ]]>RI Nicholson, IR Hutcheson, ME Harper, JM Knowlden, D Barrow, RA McClelland, HE Jones, AE Wakeling, JM Gee2001-09-0110.1677/erc.0.0080175Society for Endocrinology<![CDATA[The epidermal growth factor receptor as a target for cancer therapy]]>
http://erc.endocrinology-journals.org/cgi/content/short/8/1/3?rss=1&ssource=mfc
Mar 1, 2001; 8:3-9 ]]>J Mendelsohn2001-03-0110.1677/erc.0.0080003Society for Endocrinology<![CDATA[Mechanisms implicated in the growth regulatory effects of vitamin D in breast cancer]]>
http://erc.endocrinology-journals.org/cgi/content/short/9/1/45?rss=1&ssource=mfc
Mar 1, 2002; 9:45-59 ]]>KW Colston, CM Hansen2002-03-0110.1677/erc.0.0090045Society for Endocrinology<![CDATA[Target-based agents against ErbB receptors and their ligands: a novel approach to cancer treatment]]>
http://erc.endocrinology-journals.org/cgi/content/short/10/1/1?rss=1&ssource=mfc
Mar 1, 2003; 10:1-21 ]]>N Normanno, C Bianco, A De Luca, MR Maiello, DS Salomon2003-03-0110.1677/erc.0.0100001Society for Endocrinology<![CDATA[Histological and biological evolution of human premalignant breast disease]]>
http://erc.endocrinology-journals.org/cgi/content/short/8/1/47?rss=1&ssource=mfc
Mar 1, 2001; 8:47-61 ]]>DC Allred, SK Mohsin, SA Fuqua2001-03-0110.1677/erc.0.0080047Society for Endocrinology<![CDATA[Prostate cancer: molecular biology of early progression to androgen independence]]>
http://erc.endocrinology-journals.org/cgi/content/short/6/4/487?rss=1&ssource=mfc
Dec 1, 1999; 6:487-502 ]]>MD Sadar, M Hussain, N Bruchovsky1999-12-0110.1677/erc.0.0060487Society for Endocrinology<![CDATA[MicroRNA deregulation in human thyroid papillary carcinomas]]>
http://erc.endocrinology-journals.org/cgi/content/short/13/2/497?rss=1&ssource=mfc
Jun 1, 2006; 13:497-508 Research]]>P Pallante, R Visone, M Ferracin, A Ferraro, M T Berlingieri, G Troncone, G Chiappetta, C G Liu, M Santoro, M Negrini, C M Croce, A Fusco2006-06-0110.1677/erc.1.01209Society for Endocrinology<![CDATA[Loss of ER{beta} expression as a common step in estrogen-dependent tumor progression]]>
http://erc.endocrinology-journals.org/cgi/content/short/11/3/537?rss=1&ssource=mfc
Sep 1, 2004; 11:537-551 Original Research]]>A Bardin, N Boulle, G Lazennec, F Vignon, P Pujol2004-09-0110.1677/erc.1.00800Society for Endocrinology<![CDATA[Estrogen receptor beta in breast cancer]]>
http://erc.endocrinology-journals.org/cgi/content/short/9/1/1?rss=1&ssource=mfc
Mar 1, 2002; 9:1-13 ]]>C Palmieri, GJ Cheng, S Saji, M Zelada-Hedman, A Warri, Z Weihua, S Van Noorden, T Wahlstrom, RC Coombes, M Warner, JA Gustafsson2002-03-0110.1677/erc.0.0090001Society for Endocrinology<![CDATA[PTEN, a unique tumor suppressor gene]]>
http://erc.endocrinology-journals.org/cgi/content/short/7/2/115?rss=1&ssource=mfc
Jun 1, 2000; 7:115-129 ]]>PL Dahia2000-06-0110.1677/erc.0.0070115Society for Endocrinology<![CDATA[c-Myc in breast cancer]]>
http://erc.endocrinology-journals.org/cgi/content/short/7/3/143?rss=1&ssource=mfc
Sep 1, 2000; 7:143-164 ]]>DJ Liao, RB Dickson2000-09-0110.1677/erc.0.0070143Society for Endocrinology<![CDATA[Aromatase and breast cancer susceptibility]]>
http://erc.endocrinology-journals.org/cgi/content/short/6/2/165?rss=1&ssource=mfc
Jun 1, 1999; 6:165-173 ]]>NM Probst-Hensch, SA Ingles, AT Diep, RW Haile, FZ Stanczyk, LN Kolonel, BE Henderson1999-06-0110.1677/erc.0.0060165Society for Endocrinology<![CDATA[EGF mutant receptor vIII as a molecular target in cancer therapy]]>
http://erc.endocrinology-journals.org/cgi/content/short/8/2/83?rss=1&ssource=mfc
Jun 1, 2001; 8:83-96 ]]>CT Kuan, CJ Wikstrand, DD Bigner2001-06-0110.1677/erc.0.0080083Society for Endocrinology<![CDATA[Neuroendocrine cells in tumour growth of the prostate]]>
http://erc.endocrinology-journals.org/cgi/content/short/6/4/503?rss=1&ssource=mfc
Dec 1, 1999; 6:503-519 ]]>PA Abrahamsson1999-12-0110.1677/erc.0.0060503Society for Endocrinology<![CDATA[Androgen receptors in prostate cancer]]>
http://erc.endocrinology-journals.org/cgi/content/short/9/3/155?rss=1&ssource=mfc
Sep 1, 2002; 9:155-170 ]]>Z Culig, H Klocker, G Bartsch, A Hobisch2002-09-0110.1677/erc.0.0090155Society for Endocrinology<![CDATA[Overexpression of HER-2 as a resistance mechanism to hormonal therapy for breast cancer]]>
http://erc.endocrinology-journals.org/cgi/content/short/8/3/191?rss=1&ssource=mfc
Sep 1, 2001; 8:191-195 ]]>M Dowsett2001-09-0110.1677/erc.0.0080191Society for Endocrinology<![CDATA[Prospects for phosphoinositide 3-kinase inhibition as a cancer treatment]]>
http://erc.endocrinology-journals.org/cgi/content/short/8/3/237?rss=1&ssource=mfc
Sep 1, 2001; 8:237-248 ]]>RC Stein2001-09-0110.1677/erc.0.0080237Society for Endocrinology<![CDATA[Multiple endocrine neoplasia type 1]]>
http://erc.endocrinology-journals.org/cgi/content/short/6/4/449?rss=1&ssource=mfc
Dec 1, 1999; 6:449-473 ]]>AA Pannett, RV Thakker1999-12-0110.1677/erc.0.0060449Society for Endocrinology<![CDATA[IGF-I, IGFBP-3 and breast cancer risk in women: The European Prospective Investigation into Cancer and Nutrition (EPIC)]]>
http://erc.endocrinology-journals.org/cgi/content/short/13/2/593?rss=1&ssource=mfc
Jun 1, 2006; 13:593-605 Research]]>S Rinaldi, P H M Peeters, F Berrino, L Dossus, C Biessy, A Olsen, A Tjonneland, K Overvad, F Clavel-Chapelon, M C Boutron-Ruault, B Tehard, G Nagel, J Linseisen, H Boeing, P H Lahmann, A Trichopoulou, D Trichopoulos, M Koliva, D Palli, S Panico, R Tumino, C Sacerdote, C H van Gils, P van Noord, D E Grobbee, H B Bueno-de-Mesquita, C A Gonzalez, A Agudo, M D Chirlaque, A Barricarte, N Larranaga, J R Quiros, S Bingham, K T Khaw, T Key, N E Allen, A Lukanova, N Slimani, R Saracci, E Riboli, R Kaaks2006-06-0110.1677/erc.1.01150Society for Endocrinology<![CDATA[High-resolution serum proteomic features for ovarian cancer detection]]>
http://erc.endocrinology-journals.org/cgi/content/short/11/2/163?rss=1&ssource=mfc
Jun 1, 2004; 11:163-178 ]]>TP Conrads, VA Fusaro, S Ross, D Johann, V Rajapakse, BA Hitt, SM Steinberg, EC Kohn, DA Fishman, G Whitely, JC Barrett, LA Liotta, Petricoin EF 3rd, TD Veenstra2004-06-0110.1677/erc.0.0110163Society for Endocrinology<![CDATA[The angiogenic factor CYR61 in breast cancer: molecular pathology and therapeutic perspectives]]>
http://erc.endocrinology-journals.org/cgi/content/short/10/2/141?rss=1&ssource=mfc
Jun 1, 2003; 10:141-152 ]]>JA Menendez, I Mehmi, DW Griggs, R Lupu2003-06-0110.1677/erc.0.0100141Society for Endocrinology<![CDATA[Similarities and distinctions in the mode of action of different classes of antioestrogens]]>
http://erc.endocrinology-journals.org/cgi/content/short/7/1/17?rss=1&ssource=mfc
Mar 1, 2000; 7:17-28 ]]>AE Wakeling2000-03-0110.1677/erc.0.0070017Society for Endocrinology<![CDATA[Stable 'portrait' of breast tumors during progression: data from biology, pathology and genetics]]>
http://erc.endocrinology-journals.org/cgi/content/short/11/3/497?rss=1&ssource=mfc
Sep 1, 2004; 11:497-522 Original Research]]>M Lacroix, R-A Toillon, G Leclercq2004-09-0110.1677/erc.1.00758Society for Endocrinology<![CDATA[Interactions between estrogen and insulin-like growth factor signaling pathways in human breast tumor cells]]>
http://erc.endocrinology-journals.org/cgi/content/short/10/2/331?rss=1&ssource=mfc
Jun 1, 2003; 10:331-345 ]]>IH Hamelers, PH Steenbergh2003-06-0110.1677/erc.0.0100331Society for Endocrinology<![CDATA[Prolactin involvement in breast cancer]]>
http://erc.endocrinology-journals.org/cgi/content/short/6/3/389?rss=1&ssource=mfc
Sep 1, 1999; 6:389-404 ]]>BK Vonderhaar1999-09-0110.1677/erc.0.0060389Society for Endocrinology<![CDATA[Mechanisms involved in the progression of androgen-independent prostate cancers: it is not only the cancer cell's fault]]>
http://erc.endocrinology-journals.org/cgi/content/short/9/1/61?rss=1&ssource=mfc
Mar 1, 2002; 9:61-73 ]]>JT Arnold, JT Isaacs2002-03-0110.1677/erc.0.0090061Society for Endocrinology<![CDATA[Factors regulating the growth of metastatic cancer in bone]]>
http://erc.endocrinology-journals.org/cgi/content/short/6/3/333?rss=1&ssource=mfc
Sep 1, 1999; 6:333-347 ]]>BF Boyce, T Yoneda, TA Guise1999-09-0110.1677/erc.0.0060333Society for Endocrinology<![CDATA[The oncogene BRAFV600E is associated with a high risk of recurrence and less differentiated papillary thyroid carcinoma due to the impairment of Na+/I- targeting to the membrane]]>
http://erc.endocrinology-journals.org/cgi/content/short/13/1/257?rss=1&ssource=mfc
Mar 1, 2006; 13:257-269 Research]]>G Riesco-Eizaguirre, P Gutierrez-Martinez, M A Garcia-Cabezas, M Nistal, P Santisteban2006-03-0110.1677/erc.1.01119Society for Endocrinology<![CDATA[Beta-catenin signaling in prostate cancer: an early perspective]]>
http://erc.endocrinology-journals.org/cgi/content/short/10/4/537?rss=1&ssource=mfc
Dec 1, 2003; 10:537-560 ]]>DR Chesire, WB Isaacs2003-12-0110.1677/erc.0.0100537Society for Endocrinology<![CDATA[The ErbB receptor tyrosine family as signal integrators]]>
http://erc.endocrinology-journals.org/cgi/content/short/8/3/151?rss=1&ssource=mfc
Sep 1, 2001; 8:151-159 ]]>NE Hynes, K Horsch, MA Olayioye, A Badache2001-09-0110.1677/erc.0.0080151Society for Endocrinology<![CDATA[The EGF-CFC family: novel epidermal growth factor-related proteins in development and cancer]]>
http://erc.endocrinology-journals.org/cgi/content/short/7/4/199?rss=1&ssource=mfc
Dec 1, 2000; 7:199-226 ]]>DS Saloman, C Bianco, AD Ebert, NI Khan, M De Santis, N Normanno, C Wechselberger, M Seno, K Williams, M Sanicola, S Foley, WJ Gullick, G Persico2000-12-0110.1677/erc.0.0070199Society for Endocrinology<![CDATA[Local estrogen biosynthesis in males and females]]>
http://erc.endocrinology-journals.org/cgi/content/short/6/2/131?rss=1&ssource=mfc
Jun 1, 1999; 6:131-137 ]]>E Simpson, G Rubin, C Clyne, K Robertson, L O''Donnell, S Davis, M Jones1999-06-0110.1677/erc.0.0060131Society for Endocrinology<![CDATA[MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle]]>
http://erc.endocrinology-journals.org/cgi/content/short/14/3/791?rss=1&ssource=mfc
Sep 1, 2007; 14:791-798 Research]]>Rosa Visone, Lucia Russo, Pierlorenzo Pallante, Ivana De Martino, Angelo Ferraro, Vincenza Leone, Eleonora Borbone, Fabio Petrocca, Hansjuerg Alder, Carlo Maria Croce, Alfredo Fusco2007-09-0110.1677/ERC-07-0129Society for Endocrinology<![CDATA[Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial]]>
http://erc.endocrinology-journals.org/cgi/content/short/12/3/657?rss=1&ssource=mfc
Sep 1, 2005; 12:657-666 Original Research]]>Alfredo Berruti, Massimo Terzolo, Paola Sperone, Anna Pia, Silvia Della Casa, David J Gross, Carlo Carnaghi, Paolo Casali, Francesco Porpiglia, Franco Mantero, Giuseppe Reimondo, Alberto Angeli, Luigi Dogliotti2005-09-0110.1677/erc.1.01025Society for Endocrinology<![CDATA[Potential role of gonadotrophin-releasing hormone (GnRH)-I and GnRH-II in the ovary and ovarian cancer]]>
http://erc.endocrinology-journals.org/cgi/content/short/10/2/169?rss=1&ssource=mfc
Jun 1, 2003; 10:169-177 ]]>SK Kang, KC Choi, HS Yang, PC Leung2003-06-0110.1677/erc.0.0100169Society for Endocrinology<![CDATA[Use of aromatase inhibitors in breast carcinoma]]>
http://erc.endocrinology-journals.org/cgi/content/short/6/1/75?rss=1&ssource=mfc
Mar 1, 1999; 6:75-92 ]]>RJ Santen, HA Harvey1999-03-0110.1677/erc.0.0060075Society for Endocrinology<![CDATA[Molecular mechanisms of steroid hormone action]]>
http://erc.endocrinology-journals.org/cgi/content/short/5/1/1?rss=1&ssource=mfc
Mar 1, 1998; 5:1-14 ARTICLE]]>R White, M G Parker1998-03-0110.1677/erc.0.0050001Society for Endocrinology<![CDATA[Epidermal growth factor receptor/HER2/insulin-like growth factor receptor signalling and oestrogen receptor activity in clinical breast cancer]]>
http://erc.endocrinology-journals.org/cgi/content/short/12/Supplement_1/S99?rss=1&ssource=mfc
Jul 1, 2005; 12:99-111 Conference Papers]]>J M Gee, J F Robertson, E Gutteridge, I O Ellis, S E Pinder, M Rubini, R I Nicholson2005-07-0110.1677/erc.1.01005Society for Endocrinology<![CDATA[The expression and function of estrogen receptor alpha and beta in human breast cancer and its clinical application]]>
http://erc.endocrinology-journals.org/cgi/content/short/10/2/193?rss=1&ssource=mfc
Jun 1, 2003; 10:193-202 ]]>SI Hayashi, H Eguchi, K Tanimoto, T Yoshida, Y Omoto, A Inoue, N Yoshida, Y Yamaguchi2003-06-0110.1677/erc.0.0100193Society for Endocrinology<![CDATA[Targeting of multiple signalling pathways by heat shock protein 90 molecular chaperone inhibitors]]>
http://erc.endocrinology-journals.org/cgi/content/short/13/Supplement_1/S125?rss=1&ssource=mfc
Dec 1, 2006; 13:125-135 Conference Papers]]>Marissa V Powers, Paul Workman2006-12-0110.1677/erc.1.01324Society for Endocrinology